Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-823.78%
↑ 14% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-954.59%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -823.78% | -198.2% |
| 2024 | -276.28% | +25.2% |
| 2023 | -369.46% | -30.3% |
| 2022 | -283.53% | +70.3% |
| 2021 | -953.42% | -30.9% |
| 2020 | -728.09% | +65.9% |
| 2019 | -2134.71% | -166.7% |
| 2018 | -800.53% | +74.8% |
| 2017 | -3176.05% | - |
| 2016 | 0.00% | - |